GlobeNewswire 12/8/2025 Immutep and Dr. Reddy’s enters into Strategic Collaboration for Commercialisation of an Innovative O...
GlobeNewswire 12/8/2025 ASH 2025 | Ascentage Pharma Presents Encouraging Data from Phase Ib/II Study of Bcl-2 Inhibitor Lisa...
GlobeNewswire 12/6/2025 Ascentage Pharma Presents Pivotal China Registrational Study Data for Lisaftoclax in Oral Report at ...
Newsfile Corp 12/5/2025 TempraMed Expands European Footprint with Distribution Partnership in Netherlands, Belgium, and Luxe...
GlobeNewswire 12/5/2025 Ascentage Pharma Announces Global Registrational Phase III Study of Olverembatinib in First-Line Tre...
GlobeNewswire 12/3/2025 The Efficiency Gap: Five Assets Where Price Has Yet To Reflect Reality
GlobeNewswire 12/2/2025 Health-ISAC® Announces results of 2026 Board of Directors Election
GlobeNewswire 12/2/2025 Chronic Rare Diseases in an Aging America: Why HyBryte and Federal Policy Matter Now
GlobeNewswire 12/2/2025 Immutep to Present New Data from AIPAC-003 Phase II at the 2025 San Antonio Breast Cancer Symposium
GlobeNewswire 12/2/2025 Ventyx Provides Clinical and Corporate Updates
TeleTrader 12/1/2025 US closes lower, Dow drops 420 pts
GlobeNewswire 12/1/2025 AIM ImmunoTech to Participate in Live ‘Fireside’ Chat on Virtual Investor Closing Bell Series
GlobeNewswire 12/1/2025 Ascentage Pharma to Host Webcast Highlighting Key Data from ASH 2025
GlobeNewswire 12/1/2025 Salarius Pharmaceuticals to Collaborate with Texas Biomedical Research Institute on Avian Flu Study
GlobeNewswire 12/1/2025 Neuphoria Provides Facts, Exposes False Narratives in Response to Lynx1 Fictions
GlobeNewswire 11/28/2025 Halper Sadeh LLC Encourages AXTA, SEMR, CDTX Shareholders to Contact the Firm to Discuss Their Right...
GlobeNewswire 11/28/2025 HAPPY THANKSGIVING AND ALERT: The M&A Class Action Firm Continues to Investigate the Merger – EXAS, ...
TeleTrader 11/25/2025 US closes higher, Dow jumps over 600 pts
GlobeNewswire 11/25/2025 Amphista Therapeutics announces new AMX-883 data to be presented at the ASH Annual Meeting and Expos...
GlobeNewswire 11/25/2025 Ascentage Pharma Announces Publication of Olverembatinib Phase Ib Safety, Efficacy and Novel Mechani...
TeleTrader 11/24/2025 US closes higher with rate cut hopes in focus
TeleTrader 11/24/2025 US opens higher as holiday week begins
GlobeNewswire 11/24/2025 Biotech Valuations Rise as New Clinical Platforms Show Progress
GlobeNewswire 11/24/2025 Neuphoria Therapeutics Inc. Sends Letter to Stockholders
GlobeNewswire 11/22/2025 Halper Sadeh LLC Encourages THS, CDTX, SPNS Shareholders to Contact the Firm to Discuss Their Rights